Patient and Provider Assessment of Lipid Management Registry (PALM)
Sponsor: Duke University
Listed as NCT02341664, this observational or N/A phase trial focuses on Angina and Atherosclerosis and remains completed. Sponsored by Duke University, it has been updated 8 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
-
Apr 2019 — Apr 2020 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Regeneron Pharmaceuticals
- Sanofi
For direct contact, visit the study record on ClinicalTrials.gov .